MENU
+Compare
ATOS
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$0.97
Change
-$0.01 (-1.02%)
Capitalization
121.66M

ATOS Atossa Therapeutics Forecast, Technical & Fundamental Analysis

a manufacturer of products for breast cancer

Industry Biotechnology
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ATOS with price predictions
Dec 20, 2024

Momentum Indicator for ATOS turns negative, indicating new downward trend

ATOS saw its Momentum Indicator move below the 0 level on December 10, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In of the 82 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ATOS turned negative on December 12, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

ATOS moved below its 50-day moving average on November 13, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ATOS crossed bearishly below the 50-day moving average on November 18, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for ATOS moved below the 200-day moving average on December 06, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ATOS entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATOS advanced for three days, in of 234 cases, the price rose further within the following month. The odds of a continued upward trend are .

ATOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.645) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). ATOS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (255.281).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ATOS is expected to report earnings to rise 8.33% to -6 cents per share on March 27

Atossa Therapeutics ATOS Stock Earnings Reports
Q4'24
Est.
$-0.06
Q3'24
Est.
$-0.06
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.02
Q4'23
Est.
$-0.06
The last earnings report on November 12 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 1.09M shares outstanding, the current market capitalization sits at 121.66M.
A.I. Advisor
published General Information

General Information

a manufacturer of products for breast cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
107 Spring Street
Phone
+1 206 588-0256
Employees
12
Web
https://www.atossatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNNMY2.700.04
+1.50%
Hennes & Mauritz AB
AAIGF7.010.04
+0.50%
AIA Group, Ltd.
AFLYY0.83N/A
-0.08%
Air France-KLM
BKRIY9.01-0.03
-0.33%
Bank Ireland Group PLC
UURAF0.47-0.01
-2.30%
Ucore Rare Metals, Inc.

ATOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with MDGL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
-1.66%
MDGL - ATOS
45%
Loosely correlated
+5.12%
AXON - ATOS
42%
Loosely correlated
+2.60%
ABOS - ATOS
42%
Loosely correlated
+2.78%
ABCL - ATOS
40%
Loosely correlated
+5.17%
GBIO - ATOS
38%
Loosely correlated
+10.19%
More